| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 199.88M | — |
| Operating expense | — | — |
| Net income | -15.05M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, COLL returned -30.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -41.4% |
| 1 year | -30.7% |
| 5 years | +32.1% |
| 10 years | +225.5% |
| All-time high | $46.68 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in COLL would be worth today ›No. Collegium Pharmaceutical, Inc. has not paid a dividend in the past 12 months.
Collegium Pharmaceutical, Inc. stock trades on NASDAQ under the ticker symbol COLL.
Collegium Pharmaceutical, Inc. is part of the Healthcare sector.
Collegium Pharmaceutical, Inc. has a market cap of 840.39M USD, based on the latest quote.
Collegium Pharmaceutical, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.